Header Logo

Connection

Naoko Takebe to Receptor, trkA

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Receptor, trkA.
Naoko Takebe
Connection Strength
0.061
Receptor, trkA
  1. Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E. JCO Precis Oncol. 2026 Feb; 10:e2500612.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.